General Information of Drug Off-Target (DOT) (ID: OTHQG16J)

DOT Name G protein-activated inward rectifier potassium channel 1 (KCNJ3)
Synonyms GIRK-1; Inward rectifier K(+) channel Kir3.1; Potassium channel, inwardly rectifying subfamily J member 3
Gene Name KCNJ3
UniProt ID
KCNJ3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF01007 ; PF17655
Sequence
MSALRRKFGDDYQVVTTSSSGSGLQPQGPGQDPQQQLVPKKKRQRFVDKNGRCNVQHGNL
GSETSRYLSDLFTTLVDLKWRWNLFIFILTYTVAWLFMASMWWVIAYTRGDLNKAHVGNY
TPCVANVYNFPSAFLFFIETEATIGYGYRYITDKCPEGIILFLFQSILGSIVDAFLIGCM
FIKMSQPKKRAETLMFSEHAVISMRDGKLTLMFRVGNLRNSHMVSAQIRCKLLKSRQTPE
GEFLPLDQLELDVGFSTGADQLFLVSPLTICHVIDAKSPFYDLSQRSMQTEQFEIVVILE
GIVETTGMTCQARTSYTEDEVLWGHRFFPVISLEEGFFKVDYSQFHATFEVPTPPYSVKE
QEEMLLMSSPLIAPAITNSKERHNSVECLDGLDDITTKLPSKLQKITGREDFPKKLLRMS
STTSEKAYSLGDLPMKLQRISSVPGNSEEKLVSKTTKMLSDPMSQSVADLPPKLQKMAGG
AARMEGNLPAKLRKMNSDRFT
Function
This potassium channel is controlled by G proteins. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. This receptor plays a crucial role in regulating the heartbeat.
KEGG Pathway
Circadian entrainment (hsa04713 )
Retrograde endocan.binoid sig.ling (hsa04723 )
Glutamatergic sy.pse (hsa04724 )
Cholinergic sy.pse (hsa04725 )
Serotonergic sy.pse (hsa04726 )
Dopaminergic sy.pse (hsa04728 )
Estrogen sig.ling pathway (hsa04915 )
Oxytocin sig.ling pathway (hsa04921 )
GnRH secretion (hsa04929 )
Morphine addiction (hsa05032 )
Reactome Pathway
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits (R-HSA-997272 )
Activation of G protein gated Potassium channels (R-HSA-1296041 )

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 5 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Haloperidol DM96SE0 Approved G protein-activated inward rectifier potassium channel 1 (KCNJ3) increases the Seizures (incl subtypes) ADR of Haloperidol. [11]
Thioridazine DM35M8J Approved G protein-activated inward rectifier potassium channel 1 (KCNJ3) increases the Seizures (incl subtypes) ADR of Thioridazine. [11]
Clonidine DM6RZ9Q Approved G protein-activated inward rectifier potassium channel 1 (KCNJ3) increases the Seizures (incl subtypes) ADR of Clonidine. [11]
Pimozide DMW83TP Approved G protein-activated inward rectifier potassium channel 1 (KCNJ3) increases the Seizures (incl subtypes) ADR of Pimozide. [11]
NAPQI DM8F5LR Investigative G protein-activated inward rectifier potassium channel 1 (KCNJ3) affects the response to substance of NAPQI. [12]
------------------------------------------------------------------------------------
10 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin increases the expression of G protein-activated inward rectifier potassium channel 1 (KCNJ3). [1]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of G protein-activated inward rectifier potassium channel 1 (KCNJ3). [2]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of G protein-activated inward rectifier potassium channel 1 (KCNJ3). [3]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide decreases the expression of G protein-activated inward rectifier potassium channel 1 (KCNJ3). [4]
Triclosan DMZUR4N Approved Triclosan increases the expression of G protein-activated inward rectifier potassium channel 1 (KCNJ3). [5]
Ethinyl estradiol DMODJ40 Approved Ethinyl estradiol decreases the expression of G protein-activated inward rectifier potassium channel 1 (KCNJ3). [6]
Propranolol DM79NTF Approved Propranolol increases the expression of G protein-activated inward rectifier potassium channel 1 (KCNJ3). [7]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of G protein-activated inward rectifier potassium channel 1 (KCNJ3). [8]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of G protein-activated inward rectifier potassium channel 1 (KCNJ3). [9]
Manganese DMKT129 Investigative Manganese increases the expression of G protein-activated inward rectifier potassium channel 1 (KCNJ3). [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)

References

1 Atrial-like Engineered Heart Tissue: An In?Vitro Model of the Human Atrium. Stem Cell Reports. 2018 Dec 11;11(6):1378-1390. doi: 10.1016/j.stemcr.2018.10.008. Epub 2018 Nov 8.
2 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
3 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
4 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
5 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
6 The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. Toxicol Sci. 2009 Jan;107(1):40-55.
7 Expression of inwardly rectifying potassium channels (GIRKs) and beta-adrenergic regulation of breast cancer cell lines. BMC Cancer. 2004 Dec 16;4:93. doi: 10.1186/1471-2407-4-93.
8 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
9 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
10 Gene expression profiling of human primary astrocytes exposed to manganese chloride indicates selective effects on several functions of the cells. Neurotoxicology. 2007 May;28(3):478-89.
11 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
12 Acetaminophen-NAPQI hepatotoxicity: a cell line model system genome-wide association study. Toxicol Sci. 2011 Mar;120(1):33-41. doi: 10.1093/toxsci/kfq375. Epub 2010 Dec 22.